Back to Search Start Over

Development of the Metabolic Syndrome: Study Design and Baseline Data of the Lufthansa Prevention Study (LUPS), A Prospective Observational Cohort Survey.

Authors :
Müller-Wieland, Dirk
Altenburg, Christiane
Becher, Heiko
Burchard, Janine
Frisch, Anett
Gebhard, Jan
Haas, Jutta
Harth, Volker
Heeren, Jörg
Hengelbrock, Johannes
von Karais, Maximilian
Knebel, Birgit
Kotzka, Jörg
Löwe, Bernd
Marx, Nikolaus
Pinnschmidt, Hans
Preisser, Alexandra
Rose, Matthias
Sawitzky-Rose, Barbara
Scheja, Ludger
Source :
Experimental & Clinical Endocrinology & Diabetes; 2020, Vol. 128 Issue 12, p777-787, 11p
Publication Year :
2020

Abstract

The Lufthansa Prevention Study (LUPS) study is a prospective observation of a healthy worker cohort to identify early changes in metabolism leading to the Metabolic Syndrome (MetS) and to analyze their relation to behavioral factors like nutrition, physical activity, psychological status, and to underlying genetic conditions. The LUPS study recruited a sample of 1.962 non-diabetic healthy adults between 25–60 years, employed at a flight base of Lufthansa Technik GmbH in Hamburg, Germany. Baseline assessments included anthropometric measures, blood and urine samples and medical history. Psychosocial variables, dietary habits and life-style risk factors were assessed via self-reported questionnaires. In this report we describe the study design and present baseline parameters including the prevalence of the MetS using different classification criteria. The MetS was present in 20% of male and 12% of female subjects according to the 'Harmonizing the metabolic syndrome' definition. The prevalence varies between 2.6% in male and 2.3% in female subjects up to 48% in male and 41% in female subjects according to different classification criteria of MetS. In conclusion, this first cross-sectional view on the LUPS data confirms the expectation that this cohort is rather healthy and thus provides the opportunity to analyze early changes associated with the development of the MetS. The LUPS study is registered as a clinical trial NCT01313156. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09477349
Volume :
128
Issue :
12
Database :
Complementary Index
Journal :
Experimental & Clinical Endocrinology & Diabetes
Publication Type :
Academic Journal
Accession number :
147366325
Full Text :
https://doi.org/10.1055/a-0767-6361